Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery

Orchestration of nanoparticles to achieve targeting has become the mainstream for efficient delivery of antitumor drugs. However, the low delivery efficiency becomes the biggest barrier for clinical translation of cancer nanomedicines, as most of them are sequestrated in the liver where more macroph...

Full description

Bibliographic Details
Main Authors: Jifu Hao, Te Han, Meixiang Wang, Qiannan Zhuang, Xiaodan Wang, Jianguo Liu, Yongan Wang, Hua Tang
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Drug Delivery
Subjects:
Online Access:http://dx.doi.org/10.1080/10717544.2018.1474965
_version_ 1818290508906102784
author Jifu Hao
Te Han
Meixiang Wang
Qiannan Zhuang
Xiaodan Wang
Jianguo Liu
Yongan Wang
Hua Tang
author_facet Jifu Hao
Te Han
Meixiang Wang
Qiannan Zhuang
Xiaodan Wang
Jianguo Liu
Yongan Wang
Hua Tang
author_sort Jifu Hao
collection DOAJ
description Orchestration of nanoparticles to achieve targeting has become the mainstream for efficient delivery of antitumor drugs. However, the low delivery efficiency becomes the biggest barrier for clinical translation of cancer nanomedicines, as most of them are sequestrated in the liver where more macrophages located in are responsible for capture of systemic administrated nanoparticles. In this study, we found that the depletion of the liver macrophages could lead to a superior improvement in the nanoparticles delivery. Firstly, we developed clodronate-containing liposomes (clodrolip) to transiently suppress the phagocytic function of macrophages, the residual macrophages in liver only accounted for less than 1% when the mice were treated with clodrolip in advance. In addition, the pharmacokinetics results of treatment with paclitaxel-poly(lactic-co-glycolic acid) (PTX-PLGA) nanoparticles disclosed that the AUC of PTX in the macrophages depletion group increased 2.11-fold. These results meant that the removal of macrophages would decrease the nanoparticles accumulation in the liver and better the biodistribution and bioavailability of nanoparticles delivery systems. Moreover, treatment of mice with melanoma by the combination of clodrolip and PTX-PLGA nanoparticles resulted in an elevated anti-tumor efficacy, the tumor inhibition ratio was nearly reached to 80%. Furthermore, these combinatorial regimens have demonstrated negligible toxicity in incidence of adverse effects. In conclusion, the encouraging results from this study inspire the generation of a rational strategy to focus on microenvironmental priming for modulation of innate immunity and to improve delivery efficiency of nanoparticles.
first_indexed 2024-12-13T02:29:18Z
format Article
id doaj.art-b1a810a024e442d2b5b41a502d7bb8d3
institution Directory Open Access Journal
issn 1071-7544
1521-0464
language English
last_indexed 2024-12-13T02:29:18Z
publishDate 2018-01-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj.art-b1a810a024e442d2b5b41a502d7bb8d32022-12-22T00:02:33ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642018-01-012511289130110.1080/10717544.2018.14749651474965Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor deliveryJifu Hao0Te Han1Meixiang Wang2Qiannan Zhuang3Xiaodan Wang4Jianguo Liu5Yongan Wang6Hua Tang7Taishan Medical UniversityTaishan Medical UniversityInstitute of Immunology, Taishan Medical UniversityTaishan Medical UniversityTaishan Medical UniversityInstitute of Immunology, Taishan Medical UniversityInstitute of Immunology, Taishan Medical UniversityInstitute of Immunology, Taishan Medical UniversityOrchestration of nanoparticles to achieve targeting has become the mainstream for efficient delivery of antitumor drugs. However, the low delivery efficiency becomes the biggest barrier for clinical translation of cancer nanomedicines, as most of them are sequestrated in the liver where more macrophages located in are responsible for capture of systemic administrated nanoparticles. In this study, we found that the depletion of the liver macrophages could lead to a superior improvement in the nanoparticles delivery. Firstly, we developed clodronate-containing liposomes (clodrolip) to transiently suppress the phagocytic function of macrophages, the residual macrophages in liver only accounted for less than 1% when the mice were treated with clodrolip in advance. In addition, the pharmacokinetics results of treatment with paclitaxel-poly(lactic-co-glycolic acid) (PTX-PLGA) nanoparticles disclosed that the AUC of PTX in the macrophages depletion group increased 2.11-fold. These results meant that the removal of macrophages would decrease the nanoparticles accumulation in the liver and better the biodistribution and bioavailability of nanoparticles delivery systems. Moreover, treatment of mice with melanoma by the combination of clodrolip and PTX-PLGA nanoparticles resulted in an elevated anti-tumor efficacy, the tumor inhibition ratio was nearly reached to 80%. Furthermore, these combinatorial regimens have demonstrated negligible toxicity in incidence of adverse effects. In conclusion, the encouraging results from this study inspire the generation of a rational strategy to focus on microenvironmental priming for modulation of innate immunity and to improve delivery efficiency of nanoparticles.http://dx.doi.org/10.1080/10717544.2018.1474965macrophages depletionpaclitaxelplga nanoparticlesclodrolipantitumor effect
spellingShingle Jifu Hao
Te Han
Meixiang Wang
Qiannan Zhuang
Xiaodan Wang
Jianguo Liu
Yongan Wang
Hua Tang
Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery
Drug Delivery
macrophages depletion
paclitaxel
plga nanoparticles
clodrolip
antitumor effect
title Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery
title_full Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery
title_fullStr Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery
title_full_unstemmed Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery
title_short Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery
title_sort temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery
topic macrophages depletion
paclitaxel
plga nanoparticles
clodrolip
antitumor effect
url http://dx.doi.org/10.1080/10717544.2018.1474965
work_keys_str_mv AT jifuhao temporarysuppressionthesequestratedfunctionofhostmacrophagesforbetternanoparticlestumordelivery
AT tehan temporarysuppressionthesequestratedfunctionofhostmacrophagesforbetternanoparticlestumordelivery
AT meixiangwang temporarysuppressionthesequestratedfunctionofhostmacrophagesforbetternanoparticlestumordelivery
AT qiannanzhuang temporarysuppressionthesequestratedfunctionofhostmacrophagesforbetternanoparticlestumordelivery
AT xiaodanwang temporarysuppressionthesequestratedfunctionofhostmacrophagesforbetternanoparticlestumordelivery
AT jianguoliu temporarysuppressionthesequestratedfunctionofhostmacrophagesforbetternanoparticlestumordelivery
AT yonganwang temporarysuppressionthesequestratedfunctionofhostmacrophagesforbetternanoparticlestumordelivery
AT huatang temporarysuppressionthesequestratedfunctionofhostmacrophagesforbetternanoparticlestumordelivery